CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, confirms that, in accordance with the provisions of the ...

All eyes are on the French capital next week to see if U.S. President Donald Trump’s administration can find common ground ...

Ladies and gentlemen, welcome to the Cognizant Technology Solutions’ Fourth Quarter 2024 Earnings Conference Call. All lines ...

Cassandra’ is a Netflix German show that revolves around a family who find themselves becoming inadvertent prey in a game of ...

Ravi Singisetti; Chief Executive Officer, Director; Cognizant Technology Solutions Corp Jatin Dalal; Chief Financial Officer; Cognizant Technology Solutions Corp Thank you, operator, and good ...

Two IDF reservist soldiers were killed and eight were wounded in a terrorist shooting attack at a military stand near Tayasir ...

The capsid license follows an agreement between Dyno and Roche originally announced in May 2020 and marks Dyno’s first adeno-associated virus (AAV) capsid licensing and partnership completion.

A new European Wetland Map shows Europe's peatlands, floodplains and coastal wetlands more comprehensively than ever before ...

Chugai Pharm signs collaboration agreement with GSK's Global Health Unit for development of anti-dengue virus antibody: Tokyo Friday, January 31, 2025, 09:00 Hrs [IST] Chugai Phar ...

For the first time since the Genoa Planning Commission recommended denial of a rezoning request from developers behind the ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

As artificial intelligence continues to revolutionize industries, businesses are facing increasing pressure to integrate AI ...